GeneOne Life Science Inc Strategic Asset Allocation Index
GeneOne Life Science Inc strategic asset allocation index. GeneOne Life Science Inc (011000) has a Strategic Asset Allocation Index of 92.0% as of June 2023. Strategic assets (PP&E of ₩150.96 Billion plus long-term investments of ₩-) total ₩150.96 Billion, measured against net assets of ₩164.13 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 011000 net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of GeneOne Life Science Inc (2009–2022)
Strategic asset allocation index of GeneOne Life Science Inc from 2009 to 2022. This chart shows how GeneOne Life Science Inc's Strategic Asset Allocation Index has evolved across 14 annual periods from 2009 to 2022. As of June 2023, the index stands at 92.0%, representing strategic assets of ₩150.96 Billion against net assets of ₩164.13 Billion KRW. Check GeneOne Life Science Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
GeneOne Life Science Inc Strategic Asset Allocation Index by Year (2009–2022)
GeneOne Life Science Inc strategic asset allocation index by year from 2009 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for GeneOne Life Science Inc from 2009 to 2022, covering 14 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see GeneOne Life Science Inc (011000) total market value.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 79.6% | ₩144.37 Billion | ₩144.37 Billion | ₩- | ₩181.47 Billion | ▲ +25.8 pp |
| 2021 | 53.7% | ₩110.38 Billion | ₩110.38 Billion | ₩- | ₩205.45 Billion | ▲ +31.0 pp |
| 2020 | 22.8% | ₩22.43 Billion | ₩22.43 Billion | ₩- | ₩98.51 Billion | ▼ -20.0 pp |
| 2019 | 42.8% | ₩10.29 Billion | ₩10.00 Billion | ₩284.17 Million | ₩24.06 Billion | ▲ +20.8 pp |
| 2018 | 21.9% | ₩6.44 Billion | ₩6.11 Billion | ₩332.62 Million | ₩29.41 Billion | ▲ +11.6 pp |
| 2017 | 10.3% | ₩3.76 Billion | ₩3.43 Billion | ₩329.13 Million | ₩36.54 Billion | ▼ -3.4 pp |
| 2016 | 13.7% | ₩4.91 Billion | ₩4.29 Billion | ₩620.70 Million | ₩35.85 Billion | ▲ +4.5 pp |
| 2015 | 9.2% | ₩3.63 Billion | ₩3.05 Billion | ₩583.08 Million | ₩39.44 Billion | ▲ +2.0 pp |
| 2014 | 7.2% | ₩2.49 Billion | ₩1.70 Billion | ₩786.98 Million | ₩34.73 Billion | ▼ -2.8 pp |
| 2013 | 10.0% | ₩2.37 Billion | ₩1.43 Billion | ₩943.68 Million | ₩23.71 Billion | ▲ +3.1 pp |
| 2012 | 6.9% | ₩1.86 Billion | ₩1.86 Billion | ₩- | ₩26.74 Billion | ▼ -0.8 pp |
| 2011 | 7.7% | ₩2.61 Billion | ₩2.61 Billion | ₩- | ₩33.79 Billion | ▼ -10.1 pp |
| 2010 | 17.8% | ₩5.72 Billion | ₩5.72 Billion | ₩- | ₩32.04 Billion | ▲ +3.2 pp |
| 2009 | 14.7% | ₩5.82 Billion | ₩5.82 Billion | ₩- | ₩39.74 Billion | — |